Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

by Falcone Alfredo, Salvatore Lisa, Cremolini Chiara, Carlini Paolo, Milella Michele, Cuppone Federica, Vaccaro Vanja, Bria Emilio, Loupakis Fotios, Muti Paola, Sperduti Isabella, Giannarelli Diana, Cognetti Francesco
Published 2010-05-01

Retrospective exploratory analysis of <it>VEGF </it>polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

by Manzoni Mariangela, Ricci Vincenzo, Bencardino Katia, Santini Daniele, Vincenzi Bruno, Canestrari Emanuele, Galluccio Nadia, Catalano Vincenzo, Frumento Paolo, Schirripa Marta, Masi Gianluca, Cremolini Chiara, Ruzzo Annamaria, Salvatore Lisa, Loupakis Fotios, Danova Marco, Tonini Giuseppe, Magnani Mauro, Falcone Alfredo, Graziano Francesco
Published 2011-06-01